Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

Published:2010-02-23 Issue:07 Volume:13 Page:917-932
ISSN:1461-1457
Container-title:The International Journal of Neuropsychopharmacology
language:en
Short-container-title:Int. J. Neuropsychopharm.

Author:

El-Khalili Nizar,Joyce Mark,Atkinson Sarah,Buynak Robert J.,Datto Catherine,Lindgren Petter,Eriksson Hans

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

http://academic.oup.com/ijnp/article-pdf/13/7/917/1940118/13-7-917.pdf

Reference41 articles.

1. A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety

2. Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies

3. Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study

4. A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating and unravelling the novel antidepressant mechanism of action for atypical antipsychotics: repurposing the atypical antipsychotics for more comprehensive therapeutic usage;RPS Pharmacy and Pharmacology Reports;2024-06-04

2. Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials;Asian Journal of Psychiatry;2024-05

3. Medications for Depression: Monoamine Enhancers and Esketamine (Antidepressants);Tasman’s Psychiatry;2024

4. A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics;Neuropsychiatric Disease and Treatment;2023-12

5. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series;Frontiers in Psychiatry;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3